Booth 2141
Cambridge, Massachusetts, United States
Empatica is a full-stack, digital healthcare company and a pioneer in digital biomarker development and continuous health monitoring driven by AI.

Its FDA-cleared Empatica Health Monitoring Platform consists of the medical-grade EmbracePlus wearable, alongside proprietary software and validated digital biomarkers. Together they enable the accurate and continuous collection and monitoring of patient health data, remotely and unobtrusively. EmbracePlus has been developed with key partners including HHS, USAMRDC, and the NASA-funded Translational Research Institute for Space Health.

Empatica’s technology is used by thousands of institutional partners for research purposes, in trials and studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions.

Empatica’s newest offering, Empatica Actigraphy, provides researchers and clinicians with over 20 new digital measures to monitor sleep and physical activity, along with the capability to collect data continuously via the EmbracePlus wearable for up to 14 days on a single charge.